Pulmonary vasodilator use in very preterm infants in United States children’s hospitals
Early iNO and late sildenafil are used in VP infants despite limited evidence. Prospective early studies enrolling extremely preterm and SGA infants and late studies enrolling infants with early PV exposure and high-grade BPD would target current evidence gaps.
Authors
- Michael L. O’Byrne (ORCID: https://orcid.org/0000-0001-6023-1634)
- Erik A. Jensen (ORCID: https://orcid.org/0000-0002-9179-8032)
- Matthew Huber (ORCID: https://orcid.org/0000-0002-9441-7477)
- Nicolas A. Bamat (ORCID: https://orcid.org/0000-0001-6427-093X)
- David B. Frank (ORCID: https://orcid.org/0000-0002-3064-2069)
- Catherine M. Avitabile (ORCID: https://orcid.org/0000-0002-2354-5447)
- Kathleen Gibbs
- Scott A. Lorch (ORCID: https://orcid.org/0000-0003-3855-6752)
- Tomás Vega
Institutions
- Children's Hospital of Philadelphia (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Perinatology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1038/s41372-025-02309-x
- Citations
- 1
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development